Cynosure (CYNO) Tops Q1 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year
May 5, 2015 8:01 AM EDTWESTFORD, Mass., May 5, 2015 /PRNewswire/ --Â Cynosure, Inc. (Nasdaq: CYNO), which designs, manufactures and markets medical devices for aesthetic procedures and precision surgical applications worldwide, today reported financial results for the three months ended March 31, 2015.
First-Quarter Highlights:
North America product revenue growth of 45 percent Non-GAAP earnings of $0.15 per share; GAAP earnings break-even Cash and investments of $126.6 million at March 31, 2015"Cynosure delivered 21 percent year-over-year top-line growth in... More
